pharma · Acute Myeloid Leukemias · Breast Cancer
Syndax Pharmaceuticals
Syndax Pharmaceuticals clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
730 3rd Ave, Floor 9, New York, NY 10017, US HQ
325 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 730 3rd Ave, Floor 9, New York, NY 10017, US
- Employees
- 325
- Programs
- 47
- Drugs
- 29
- Patents
- 6
Syndax Pharmaceuticals projects
2 ClinicalTrials.gov programs sponsored by Syndax Pharmaceuticals.
Syndax Pharmaceuticals has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Syndax Pharmaceuticals have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.